Jason McCarthy

Stock Analyst at Maxim Group

(0)
# 4916
Out of 5,441 analysts
234
Total ratings
Success rate
Average return
119 Stocks
Name Action PT Current % Upside Ratings Updated
BCLI Brainstorm Cell
Downgrades: Hold
n/a
n/a n/a 5 Jul 23, 2025
AKTX Akari Therapeutics
Initiates Coverage On: Buy
5
1.05 376.19% 1 Jul 18, 2025
SLS SELLAS Life Sciences...
Maintains: Strong Buy
4 7
1.53 357.52% 4 Jul 16, 2025
INMB INmune Bio
Maintains: Buy
30 8
2.4 233.33% 2 Jul 2, 2025
KZIA Kazia Therapeutics
Maintains: Buy
15 15
8.17 83.6% 3 Jun 11, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 1 May 23, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
8
2.9 175.86% 2 May 20, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
6 3
0.64 368.75% 1 May 19, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
60
7.84 665.31% 1 May 19, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 2 May 14, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
3
0.6 400% 1 May 12, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
10 20
1.98 910.1% 2 May 8, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 2 May 8, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
4
1 300% 1 Mar 27, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 2 Mar 25, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
4
0.62 545.16% 3 Mar 25, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
10
2.94 240.14% 1 Mar 21, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
5 3
0.87 244.83% 2 Mar 10, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
4
n/a n/a 1 Feb 24, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
8 12
5.31 125.99% 2 Jan 30, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
24
2.2 990.91% 1 Jan 23, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
8 15
1.67 798.2% 2 Jan 16, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
7
n/a n/a 5 Jan 10, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
60 110
69.7 57.82% 2 Nov 15, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
224 140
7.8 1694.87% 2 Nov 13, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 6 Nov 8, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
6
1.58 279.75% 1 Nov 7, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
22 12
4.33 177.14% 2 Nov 1, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 4 Oct 31, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
25
2.82 786.52% 1 Oct 25, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
2 1
2.6 -61.54% 1 Oct 22, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
12 25
7.82 219.69% 2 Sep 25, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
18 25
11.7 113.68% 2 Sep 24, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
12
14.67 -18.2% 5 Sep 24, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 3 Aug 27, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
8 10
5.93 68.63% 2 Aug 6, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
30 5
1.45 244.83% 2 Aug 6, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
14
7.85 78.34% 3 Jul 11, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
25
n/a n/a 1 Jun 20, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
4 10
0.68 1370.59% 2 May 9, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
10
n/a n/a 1 May 8, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
3
n/a n/a 1 May 6, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
16
0.6 2566.67% 1 Apr 9, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
6
3.96 51.52% 1 Apr 3, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
57
0.5 11150% 1 Dec 11, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 2 Nov 15, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 1 Nov 8, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
7 10
n/a n/a 2 Sep 28, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 4 Sep 14, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 2 Sep 13, 2023